China NMPA approves Antengene’ IND application for phase Ib/II study of ATG-022 in combo with Keytruda± chemotherapy: Shanghai Wednesday, December 3, 2025, 18:00 Hrs [IST] Ante ...

Citius Oncology launches US FDA approved Lymphir, a novel cancer immunotherapy for cutaneous T-cell lymphoma: Cranford, New Jersey Wednesday, December 3, 2025, 16:00 Hrs [IST] Cit ...

Lenacapavir approved in Zambia and Zimbabwe in record time through WHO Collaborative Registration Procedure: Geneva Wednesday, December 3, 2025, 17:00 Hrs [IST] The Zambia Medicin ...

Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia: Berlin Wednesday, December 3, 2025, ...

WHO issues global guideline on the use of GLP-1 medicines in treating obesity: Geneva Wednesday, December 3, 2025, 14:00 Hrs [IST] To address the growing global health challenge o ...

AstraZeneca’s NDA for baxdrostat accepted under US FDA Priority Review in US for patients with hard-to-control hypertension: Cambridge, UK Wednesday, December 3, 2025, 09:00 Hrs ...

Roche gets US FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough: Basel Wednesday, December ...

GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition (6 - 9 December), reinforcing its potential to redefine ...

Exporters to strengthen supply chain independence as MSMEs struggle to meet revised Schedule M deadline: Shardul Nautiyal, Mumbai Wednesday, December 3, 2025, 08:00 Hrs [IST] Even ...

KSRPA urges govt to establish a dedicated veterinary drug cell within state FDA: Nandita Vijayasimha, Bengaluru Wednesday, December 3, 2025, 08:00 Hrs [IST] The Karnataka State Re ...

Despite lingering cash flow strains for MSMEs, pharma exporters have reported gradual recovery amidst depreciation of local currencies in Africa supported by RBI's rupee trade mechanisms. Exporters ...

Kiora Pharma receives US patent covering additional formulations for the KIO-100 family of anti-inflammatory compounds: Encinitas, California Wednesday, December 3, 2025, 11:00 Hr ...